# Huron Consulting Group Inc.: financial statements, quarterly

HURN · Nasdaq · CIK 1289848 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hurn.md) · [Financials](/companies/hurn/financials.md) · [Filings](/companies/hurn/filings.md) · [Insiders](/companies/hurn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hurn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [355](/filings/0001289848-24-000172.md) | [367](/filings/0001289848-24-000209.md) | [350 d](/filings/0001628280-26-011093.md) | [363](/filings/0001289848-25-000132.md) | [381](/filings/0001289848-25-000191.md) | [378](/filings/0001628280-25-046771.md) | [399 d](/filings/0001628280-26-011093.md) | [404](/filings/0001289848-26-000082.md) | [412](/filings/0001289848-25-000191.md) | [441](/filings/0001628280-25-046771.md) | [442 d](/filings/0001628280-26-011093.md) | [452](/filings/0001289848-26-000082.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [64.6](/filings/0001289848-24-000172.md) | [64.4](/filings/0001289848-24-000209.md) | [67.1 d](/filings/0001628280-26-011093.md) | [72.7](/filings/0001289848-25-000132.md) | [71.4](/filings/0001289848-25-000191.md) | [70.4](/filings/0001628280-25-046771.md) | [72.2 d](/filings/0001628280-26-011093.md) | [76.6](/filings/0001289848-26-000082.md) | [80.2](/filings/0001289848-25-000191.md) | [81.3](/filings/0001628280-25-046771.md) | [79.9 d](/filings/0001628280-26-011093.md) | [84.7](/filings/0001289848-26-000082.md) |
| Operating income | $m | [39.7](/filings/0001289848-24-000172.md) | [37.3](/filings/0001289848-24-000209.md) | [29.9 d](/filings/0001628280-26-011093.md) | [19.9](/filings/0001289848-25-000132.md) | [59.4](/filings/0001289848-25-000191.md) | [42.4](/filings/0001628280-25-046771.md) | [47.1 d](/filings/0001628280-26-011093.md) | [32.7](/filings/0001289848-26-000082.md) | [45.7](/filings/0001289848-25-000191.md) | [50.0](/filings/0001628280-25-046771.md) | [50.2 d](/filings/0001628280-26-011093.md) | [36.6](/filings/0001289848-26-000082.md) |
| Income tax | $m | [10.3](/filings/0001289848-24-000172.md) | [9.8](/filings/0001289848-24-000209.md) | [(1.1) d](/filings/0001628280-26-011093.md) | [(0.4)](/filings/0001289848-25-000132.md) | [14.6](/filings/0001289848-25-000191.md) | [10.4](/filings/0001628280-25-046771.md) | [12.8 d](/filings/0001628280-26-011093.md) | [(3.1)](/filings/0001289848-26-000082.md) | [8.3](/filings/0001289848-25-000191.md) | [12.2](/filings/0001628280-25-046771.md) | [12.6 d](/filings/0001628280-26-011093.md) | [3.8](/filings/0001289848-26-000082.md) |
| Net income | $m | [24.7](/filings/0001289848-24-000172.md) | [21.5](/filings/0001289848-24-000209.md) | [2.8 d](/filings/0001628280-26-011093.md) | [18.0](/filings/0001289848-25-000132.md) | [37.5](/filings/0001289848-25-000191.md) | [27.1](/filings/0001628280-25-046771.md) | [34.0 d](/filings/0001628280-26-011093.md) | [24.5](/filings/0001289848-26-000082.md) | [19.4](/filings/0001289848-25-000191.md) | [30.4](/filings/0001628280-25-046771.md) | [30.7 d](/filings/0001628280-26-011093.md) | [23.2](/filings/0001289848-26-000082.md) |
| Diluted EPS | $ per share | [1.27](/filings/0001289848-24-000172.md) | [1.10](/filings/0001289848-24-000209.md) | not reported | [0.95](/filings/0001289848-25-000132.md) | [2.03](/filings/0001289848-25-000191.md) | [1.47](/filings/0001628280-25-046771.md) | not reported | [1.33](/filings/0001289848-26-000082.md) | [1.09](/filings/0001289848-25-000191.md) | [1.71](/filings/0001628280-25-046771.md) | not reported | [1.34](/filings/0001289848-26-000082.md) |
| Basic EPS | $ per share | [1.30](/filings/0001289848-24-000172.md) | [1.15](/filings/0001289848-24-000209.md) | not reported | [0.99](/filings/0001289848-25-000132.md) | [2.10](/filings/0001289848-25-000191.md) | [1.53](/filings/0001628280-25-046771.md) | not reported | [1.38](/filings/0001289848-26-000082.md) | [1.12](/filings/0001289848-25-000191.md) | [1.75](/filings/0001628280-25-046771.md) | not reported | [1.37](/filings/0001289848-26-000082.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.6](/filings/0001289848-23-000086.md) | [9.4](/filings/0001289848-23-000121.md) | [12.1](/filings/0001289848-25-000032.md) | [18.6](/filings/0001289848-24-000119.md) | [17.6](/filings/0001289848-24-000172.md) | [18.5](/filings/0001289848-24-000209.md) | [21.9](/filings/0001628280-26-011093.md) | [23.4](/filings/0001289848-25-000132.md) | [61.0](/filings/0001289848-25-000191.md) | [23.9](/filings/0001628280-25-046771.md) | [24.5](/filings/0001289848-26-000082.md) | [26.5](/filings/0001289848-26-000082.md) |
| Current assets | $m | [380](/filings/0001289848-23-000086.md) | [406](/filings/0001289848-23-000121.md) | [400](/filings/0001289848-25-000032.md) | [451](/filings/0001289848-24-000119.md) | [436](/filings/0001289848-24-000172.md) | [438](/filings/0001289848-24-000209.md) | [409](/filings/0001628280-26-011093.md) | [440](/filings/0001289848-25-000132.md) | [490](/filings/0001289848-25-000191.md) | [475](/filings/0001628280-25-046771.md) | [449](/filings/0001289848-26-000082.md) | [515](/filings/0001289848-26-000082.md) |
| Total assets | $m | [1,257](/filings/0001289848-23-000086.md) | [1,282](/filings/0001289848-23-000121.md) | [1,262](/filings/0001289848-25-000032.md) | [1,347](/filings/0001289848-24-000119.md) | [1,326](/filings/0001289848-24-000172.md) | [1,329](/filings/0001289848-24-000209.md) | [1,344](/filings/0001628280-26-011093.md) | [1,364](/filings/0001289848-25-000132.md) | [1,481](/filings/0001289848-25-000191.md) | [1,544](/filings/0001628280-25-046771.md) | [1,527](/filings/0001289848-26-000082.md) | [1,589](/filings/0001289848-26-000082.md) |
| Current liabilities | $m | [200](/filings/0001289848-23-000086.md) | [265](/filings/0001289848-23-000121.md) | [303](/filings/0001289848-25-000032.md) | [188](/filings/0001289848-24-000119.md) | [226](/filings/0001289848-24-000172.md) | [271](/filings/0001289848-24-000209.md) | [339](/filings/0001628280-26-011093.md) | [211](/filings/0001289848-25-000132.md) | [247](/filings/0001289848-25-000191.md) | [330](/filings/0001628280-25-046771.md) | [383](/filings/0001289848-26-000082.md) | [232](/filings/0001289848-26-000082.md) |
| Long-term debt | $m | [395](/filings/0001289848-23-000086.md) | [358](/filings/0001289848-23-000121.md) | [324](/filings/0001289848-25-000032.md) | [559](/filings/0001289848-24-000119.md) | [497](/filings/0001289848-24-000172.md) | [428](/filings/0001289848-24-000209.md) | [343](/filings/0001628280-26-011093.md) | [562](/filings/0001289848-25-000132.md) | [643](/filings/0001289848-25-000191.md) | [590](/filings/0001628280-25-046771.md) | [490](/filings/0001289848-26-000082.md) | [835](/filings/0001289848-26-000082.md) |
| Current portion of debt | $m | not reported | not reported | [0.0](/filings/0001289848-25-000032.md) | [13.8](/filings/0001289848-24-000119.md) | [13.8](/filings/0001289848-24-000172.md) | [13.8](/filings/0001289848-24-000209.md) | [13.8](/filings/0001628280-26-011093.md) | [13.8](/filings/0001289848-25-000132.md) | [13.8](/filings/0001289848-25-000191.md) | [20.0](/filings/0001628280-25-046771.md) | [20.0](/filings/0001289848-26-000082.md) | [20.0](/filings/0001289848-26-000082.md) |
| Shareholders' equity | $m | [552](/filings/0001289848-24-000209.md) | [553](/filings/0001289848-24-000209.md) | [533](/filings/0001628280-26-011093.md) | [496](/filings/0001289848-25-000191.md) | [501](/filings/0001628280-25-046771.md) | [523](/filings/0001628280-25-046771.md) | [561](/filings/0001289848-26-000082.md) | [494](/filings/0001289848-26-000082.md) | [475](/filings/0001628280-25-046771.md) | [500](/filings/0001628280-25-046771.md) | [529](/filings/0001289848-26-000082.md) | [397](/filings/0001289848-26-000082.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [78.2 d](/filings/0001289848-24-000172.md) | [68.8 d](/filings/0001289848-24-000209.md) | [80.4 d](/filings/0001628280-26-011093.md) | [(131)](/filings/0001289848-25-000132.md) | [107 d](/filings/0001289848-25-000191.md) | [85.2 d](/filings/0001628280-25-046771.md) | [140 d](/filings/0001628280-26-011093.md) | [(107)](/filings/0001289848-26-000082.md) | [80.0 d](/filings/0001289848-25-000191.md) | [93.8 d](/filings/0001628280-25-046771.md) | [126 d](/filings/0001628280-26-011093.md) | [(162)](/filings/0001289848-26-000082.md) |
| Capital expenditure | $m | [1.8 d](/filings/0001289848-24-000172.md) | [1.4 d](/filings/0001289848-24-000209.md) | [4.3 d](/filings/0001628280-26-011093.md) | [1.2](/filings/0001289848-25-000132.md) | [2.5 d](/filings/0001289848-25-000191.md) | [2.4 d](/filings/0001628280-25-046771.md) | [2.6 d](/filings/0001628280-26-011093.md) | [1.9](/filings/0001289848-26-000082.md) | [2.0 d](/filings/0001289848-25-000191.md) | [4.0 d](/filings/0001628280-25-046771.md) | [2.6 d](/filings/0001628280-26-011093.md) | [5.7](/filings/0001289848-26-000082.md) |
| Share repurchases | $m | [15.2 d](/filings/0001289848-24-000172.md) | [28.5 d](/filings/0001289848-24-000209.md) | [33.9 d](/filings/0001628280-26-011093.md) | [61.0](/filings/0001289848-25-000132.md) | [36.3 d](/filings/0001289848-25-000191.md) | [7.3 d](/filings/0001628280-25-046771.md) | [18.5 d](/filings/0001628280-26-011093.md) | [65.3](/filings/0001289848-26-000082.md) | [69.1 d](/filings/0001289848-25-000191.md) | [18.7 d](/filings/0001628280-25-046771.md) | [13.6 d](/filings/0001628280-26-011093.md) | [153](/filings/0001289848-26-000082.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.0](/filings/0001289848-23-000086.md) | [20.6](/filings/0001289848-23-000121.md) | [19.7](/filings/0001289848-24-000119.md) | [19.5](/filings/0001289848-24-000172.md) | [19.5](/filings/0001289848-24-000209.md) | [18.9](/filings/0001289848-25-000132.md) | [18.5](/filings/0001289848-25-000191.md) | [18.5](/filings/0001628280-25-046771.md) | [18.5](/filings/0001289848-26-000082.md) | [17.8](/filings/0001289848-25-000191.md) | [17.8](/filings/0001628280-25-046771.md) | [17.4](/filings/0001289848-26-000082.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,211,829 at 2026-04-28, from the cover of the [10-Q filed 2026-05-05](/filings/0001289848-26-000082.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.